Physician profile
John M Micheletti
NPI 1487073920
$915,849.93
in general payments reported to CMS, 2019-2025
28 companies · $358K in 2025
The $358K reported for 2025 was more than what 99% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,835 · 2020: $152 · 2021: $11K · 2022: $69K · 2023: $226K · 2024: $249K · 2025: $358K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $482K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $244K · Travel and Lodging: $72K · Food and Beverage: $24K · Honoraria: $10K · Entertainment: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $481,636.10 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $244,330.95 |
| Travel and Lodging | $72,261.75 |
| Food and Beverage | $23,827.76 |
| Honoraria | $10,138.86 |
| Entertainment | $465.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $466,840.11 | 2019-2025 | Clareon, Acrysof Iq Panoptix Uv Iol, Clareon Panoptix Pro |
| Glaukos Corporation | $218,462.86 | 2021-2025 | Travoprost Intraocular Implant - Idose, Istent Inject Trabecular Micro-Bypass System Model G2-M-Is, Idose |
| Alcon Research LLC | $60,404.88 | 2021-2025 | Acrysof Iq Panoptix Uv Iol, Acrysof Iq Vivity, Unity |
| Carl Zeiss Meditec, INC. | $36,737.17 | 2019-2025 | Veracity Surgical, Clarus, Cirrus 6000 With Angioplex |
| Nova Eye, INC. | $24,306.36 | 2024-2025 | |
| Bausch & Lomb Americas INC. | $23,858.37 | 2022-2025 | Envista Mx60 Iol, Envista Envy Iol, Miebo |
| Carl Zeiss Meditec USA, INC. | $16,551.06 | 2021-2025 | Veracity Surgical, Visumax, Quatera 700 |
| Lensar, INC. | $15,897.63 | 2023-2024 | Lensar Laser System |
| New World Medical,INC. | $13,601.93 | 2022-2025 | Clearpath, Streamline, Ahmed Glaucoma Valve |
| Microsurgical Technology, INC. | $13,464.42 | 2024-2025 | |
| Abbvie INC. | $9,335.84 | 2021-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $4,891.84 | 2019-2025 | Tecnis Simplicity, Tecnis Iol, Catalys System |
| Tarsus Pharmaceuticals, INC. | $4,215.15 | 2024-2025 | Xdemvy |
| Rxsight INC | $3,314.91 | 2021-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Beaver-Visitec International, INC. | $1,962.38 | 2022-2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $830.03 | 2021-2022 | |
| Aerie Pharmaceuticals, INC. | $232.32 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $177.51 | 2019-2022 | |
| Lumibird Medical INC. | $176.25 | 2025 | |
| Dompe US, INC. | $134.46 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $120.49 | 2019-2024 | Tecnis Simplicity |
| Oyster Point Pharma, INC. | $106.85 | 2022 | |
| Sight Sciences, INC. | $54.89 | 2021-2022 | |
| Rayner Intraocular Lenses Limited | $50.87 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $45.61 | 2019-2021 | |
| Biotissue Holdings INC. | $32.57 | 2022-2024 | |
| Medtronic, INC. | $28.98 | 2025 | Valleylab Ft10 |
| Eyevance Pharmaceuticals LLC | $14.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Micheletti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.